South African variant could significantly reduce Pfizer vaccine protection, study suggests
Published
Published
Pfizer Inc and BioNTech SE are in talks with regulatory authorities about testing a vaccine modified to protect specifically..
Findings from a laboratory study suggests the dominant local coronavirus variant may reduce antibody protection from the Pfizer..